Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
Hoffmann-La Roche
Christopher Sweeney; Sergio Bracarda; Cora N Sternberg; Kim N Chi; David Olmos; Shahneen Sandhu; Christophe Massard; Nobuaki Matsubara; Boris Alekseev; Francis Parnis; Vagif Atduev; Gary L Buchschacher; Rustem Gafanov; Luis Corrales; Michael Borre; Daniil Stroyakovskiy; Gustavo Vasconcelos Alves; Evangelos Bournakis; Javier Puente; Marie-Laurence Harle-Yge; Jorge Gallo; Geng Chen; Justin Hanover; Matthew J Wongchenko; Josep Garcia; Johann S de Bono